Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Six Monthly Return

5 Dec 2008 14:28

RNS Number : 6401J
Ark Therapeutics Group PLC
05 December 2008
 



Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Unapproved Share Option Scheme 

3.  Period of return

From 3/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

2,536,252

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6.  Less: Number of securities issued/allotted under the scheme during period

5,000

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

2,531,252

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

  Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan 

3.  Period of return

From 3/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

939,433

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6.  Less: Number of securities issued/allotted under the scheme during period

Nil

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

939,433

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

  Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group 2005 Long Term Incentive Plan

3.  Period of return

From 9/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

Nil

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

1,000,000

6.  Less: Number of securities issued/allotted under the scheme during period

7,750

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

992,250

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

  Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Approved Share Option Plan

3.  Period of return

From 9/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

Nil

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

1,000,000

6.  Less: Number of securities issued/allotted under the scheme during period

Nil

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

1,000,000

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRUVUSRWRRURAA
Date   Source Headline
8th Jun 20078:00 amRNSBlocklisting Interim Review
8th Jun 20078:00 amRNSBlocklisting Interim Review
7th Jun 20077:00 amRNSKerraped Launch
31st May 200710:13 amRNSVoting Rights and Capital
31st May 20077:02 amRNSResearch Update
22nd May 20077:01 amRNSTrinam Update
2nd May 20077:01 amRNSTrinam(R) RAC Application
30th Apr 20074:10 pmRNSVoting Rights and Capital
27th Apr 20077:01 amRNSRegulatory Update
26th Apr 20075:29 pmRNSResult of AGM
24th Apr 20077:01 amRNSResearch Update
2nd Apr 20071:42 pmRNSVoting Rights and Capital
2nd Apr 200712:22 pmRNSAnnual Information Update
30th Mar 20071:57 pmRNSHolding(s) in Company
19th Mar 20072:20 pmRNSBlock Listing Application
15th Mar 20075:37 pmRNSHolding(s) in Company
12th Mar 20072:12 pmRNSHolding(s) in Company
7th Mar 20077:01 amRNSFinal Results
5th Mar 20075:33 pmRNSHolding(s) in Company
1st Mar 200710:40 amRNSVoting Rights and Capital
23rd Feb 20079:00 amRNSHolding(s) in Company
22nd Feb 20077:01 amRNSStroke Patent
16th Feb 20079:00 amRNSHolding(s) in Company
16th Feb 20077:00 amRNSResearch Update
6th Feb 20071:03 pmRNSHolding(s) in Company
5th Feb 20072:41 pmRNSOption Awards
1st Feb 20077:01 amRNSEuropean Grant Awarded
25th Jan 20075:19 pmRNSHolding(s) in Company
22nd Jan 200711:24 amRNSTotal Voting Rights
19th Jan 200712:28 pmRNSNotice of Results
15th Jan 200712:45 pmRNSRe: Award
11th Jan 20077:01 amRNSResearch Update
5th Jan 20077:53 amRNSResearch Update
20th Dec 20062:00 pmRNSHolding(s) in Company
20th Dec 200610:28 amRNSVoting and Rights Capital
18th Dec 20067:01 amRNSHolding(s) in Company
14th Dec 20067:01 amRNSPlacing of Shares
4th Dec 200611:26 amRNSBlocklisting Interim Review
4th Dec 200611:21 amRNSBlocklisting Interim Review
27th Nov 20061:44 pmRNSHolding(s) in Company
13th Oct 20067:00 amRNSCerepro Patent Granted
10th Oct 20067:01 amRNSRe: Kerraboot
2nd Oct 20063:49 pmRNSHolding(s) in Company
27th Sep 20067:01 amRNSResearch Update
8th Sep 20064:11 pmRNSHolding(s) in Company
5th Sep 20067:03 amRNSResearch Update
1st Sep 20067:00 amRNSCerepro EMEA review
30th Aug 20067:01 amRNSInterim Results
23rd Aug 20067:01 amRNSResearch Update
4th Aug 200612:50 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.